India is one of the most popular travel destinations in the world, drawing millions of visitors each year to its ancient temples, vibrant cities, and stunning natural landscapes. But behind the beauty lies a genuine health concern that every traveler must take seriously: malaria. With hundreds of thousands of malaria cases reported annually, India remains one of the highest-burden countries outside of sub-Saharan Africa. Understanding where and when malaria risk is greatest, and choosing the right antimalarial medication, can make the difference between a trip of a lifetime and a medical emergency.
In this guide, we break down malaria risk across India, highlight the states and seasons that pose the greatest danger, explain what the CDC recommends, and explore why Arakoda (tafenoquine) — the only weekly antimalarial pill — is particularly well-suited for travelers planning extended trips to the subcontinent. We will also show you how to get a prescription quickly and conveniently through Runway Health.
How Widespread Is Malaria in India?
India accounts for a significant share of the global malaria burden. According to the World Health Organization’s World Malaria Report, India contributes roughly 2-3% of all malaria cases worldwide and is responsible for the vast majority of cases in the WHO South-East Asia Region. While India has made impressive strides in reducing malaria incidence — cutting cases by more than half over the past decade — the disease remains endemic across much of the country.
Two species of the malaria parasite circulate in India. Plasmodium falciparum, the more dangerous species that can cause severe and potentially fatal malaria, accounts for a growing proportion of cases, particularly in the high-burden tribal and forested regions. Plasmodium vivax, which can cause relapsing malaria months after initial infection, is the other predominant species and is found throughout the country. Travelers to India may be exposed to either or both species, making effective prophylaxis essential.
High-Risk States: Where Malaria Hits Hardest
Malaria risk is not uniform across India. While transmission can occur in virtually any part of the country (except at altitudes above approximately 2,000 meters), certain states consistently report disproportionately high case counts. Understanding these hotspots is critical for planning your India itinerary and determining your prophylaxis needs.
Odisha
Odisha (formerly Orissa) has historically been India’s most malaria-affected state. Located on the eastern coast, it features dense tropical forests, a warm and humid climate, and large tribal populations living in remote areas with limited healthcare access. The state accounts for a substantial portion of India’s total P. falciparum cases. Travelers visiting Odisha’s wildlife sanctuaries, tribal regions, or rural areas should consider themselves at elevated risk.
Jharkhand
Jharkhand, carved out of southern Bihar in 2000, sits on the Chota Nagpur Plateau and is characterized by forested hills and mining communities. Malaria transmission is persistent here, fueled by the same combination of forest cover, monsoon rains, and underserved rural populations that drives outbreaks in Odisha. P. falciparum is the dominant species in most of Jharkhand’s affected districts.
Chhattisgarh
Chhattisgarh, in central India, contains some of the country’s most densely forested terrain. Its tribal belt, stretching across the southern and northern districts, reports consistently high malaria numbers. The Bastar region in southern Chhattisgarh is particularly notorious for year-round transmission. Travelers trekking through forested areas or visiting indigenous communities in Chhattisgarh should exercise heightened caution.
The Northeast (Meghalaya, Mizoram, Tripura, and Others)
India’s northeastern states — including Meghalaya, Mizoram, Tripura, Nagaland, Manipur, and Arunachal Pradesh — are becoming increasingly popular with adventurous travelers drawn to the region’s stunning hill landscapes, unique cultures, and relative remoteness. However, these states also experience significant malaria transmission. The heavily forested terrain, high rainfall, and proximity to Myanmar (which has its own malaria challenges) contribute to sustained risk. Both P. falciparum and P. vivax circulate in the northeast.
Other Areas of Concern
Beyond these primary hotspots, malaria transmission also occurs in parts of Madhya Pradesh, Maharashtra, Rajasthan (particularly the desert districts during and after monsoon), Gujarat, Karnataka, Goa, and West Bengal. Even major cities like Mumbai and New Delhi report malaria cases, particularly in peri-urban and slum areas where stagnant water provides breeding grounds for Anopheles mosquitoes.
Areas generally considered lower risk include high-altitude regions of Himachal Pradesh, Jammu and Kashmir (above 2,000 meters), and Sikkim. However, no region of India below 2,000 meters should be considered completely malaria-free.
Monsoon Season: When Malaria Risk Peaks
India’s monsoon season is the single most important factor driving malaria transmission patterns. The southwest monsoon typically arrives in June and retreats by September or October, drenching most of the subcontinent and creating ideal breeding conditions for Anopheles mosquitoes.
Peak malaria transmission in India generally occurs from July through November, with the highest case counts recorded in September and October as mosquito populations explode in the weeks following the heaviest rains. The standing water left behind by monsoon downpours — in rice paddies, construction sites, ditches, and forest pools — provides abundant larval habitat.
For travelers, this means that trips during or just after the monsoon carry the greatest malaria risk. However, transmission is not limited to monsoon season. In states like Chhattisgarh and parts of the northeast, malaria cases are reported year-round. Additionally, the northeast monsoon (October–December) brings rain to southern and eastern coastal regions, extending the transmission season in those areas.
Key takeaway: If you are traveling to India between June and November — especially to rural, forested, or tribal areas — malaria prophylaxis is strongly recommended. Even during the drier months, prophylaxis is advisable if your itinerary includes high-risk states.
What the CDC Recommends for Travelers to India
The CDC’s travel health recommendations for India are clear: malaria prophylaxis is recommended for travelers visiting most areas of the country. The CDC advises antimalarial medication for all travelers going to areas below 2,000 meters, which encompasses the vast majority of popular tourist destinations, business hubs, and cultural sites.
The CDC-approved antimalarial options for India include:
- Atovaquone-proguanil (Malarone) — Taken daily, starting 1-2 days before travel
- Doxycycline — Taken daily, starting 1-2 days before travel
- Mefloquine — Taken weekly, starting 2-3 weeks before travel
- Tafenoquine (Arakoda) — Taken weekly, starting 3 days before travel
Chloroquine is not effective in India due to widespread chloroquine-resistant P. falciparum. This is an important distinction, as some travelers mistakenly assume chloroquine is sufficient for the region.
In addition to medication, the CDC recommends personal protective measures: using EPA-registered insect repellents containing DEET, wearing long sleeves and pants during peak mosquito hours (dusk to dawn), sleeping under insecticide-treated bed nets in areas without screened or air-conditioned rooms, and treating clothing and gear with permethrin.
Why Arakoda (Tafenoquine) Is a Game-Changer for India Travel
Among the CDC-approved antimalarials, Arakoda (tafenoquine) stands out as a particularly compelling option for travelers heading to India — especially those planning trips of two weeks or longer. Here is why.
Weekly Dosing: Less to Remember, More Peace of Mind
The most significant advantage of Arakoda is its once-weekly dosing schedule. While atovaquone-proguanil (Malarone) and doxycycline require daily pills, Arakoda only needs to be taken once per week during your time in a malaria-endemic area. For a three-week trip to India, that is just three maintenance doses versus twenty-one daily pills with other options.
This matters enormously for travelers in India, where days are often packed with early-morning temple visits, long train journeys, overnight treks, and immersive cultural experiences. Forgetting a daily pill is remarkably easy when your routine is upended by travel. With Arakoda, you pick one day of the week, take your pill, and you are covered for the next seven days.
Short Lead Time
Arakoda’s loading dose consists of taking one tablet daily for three consecutive days before entering the malaria-endemic area. This is considerably shorter than mefloquine (the other weekly option), which requires starting two to three weeks before travel. For travelers who book trips on short notice — a common scenario for business travelers heading to India — Arakoda’s brief loading period is a practical advantage.
Ideal for Extended India Trips
India is a vast country, and many travelers spend three weeks to several months exploring its diverse regions. Backpackers traversing the subcontinent, volunteers working in rural communities, business professionals with recurring India assignments, and digital nomads basing themselves in cities like Bangalore or Goa all benefit from the simplicity of weekly dosing.
Consider the math: a six-week India trip requires approximately 42 daily pills with Malarone or doxycycline, but only about 6 weekly doses of Arakoda (plus the 3-day loading dose and a post-travel dose). Fewer pills means fewer chances to miss a dose, less luggage space devoted to medication, and a simpler routine overall.
Effective Against Both Malaria Species in India
Arakoda is effective against both P. falciparum and P. vivax, the two species responsible for malaria in India. Tafenoquine is an 8-aminoquinoline compound related to primaquine, and it has demonstrated strong efficacy in clinical trials for malaria prophylaxis. Its long half-life is what enables the weekly dosing schedule while maintaining protective drug levels in the body.
Post-Travel Protection
After leaving the malaria-endemic area, Arakoda requires just one additional dose taken seven days after the last maintenance dose. Compare this to atovaquone-proguanil, which requires seven days of post-travel dosing, or doxycycline, which requires four full weeks of daily pills after returning home. The shorter post-travel regimen improves adherence and gets you back to your normal routine faster.
Important Considerations Before Taking Arakoda
Arakoda is a highly effective antimalarial, but it is not appropriate for everyone. Before starting tafenoquine, there are several important requirements and considerations to discuss with a healthcare provider:
- G6PD testing is mandatory. Tafenoquine can cause hemolytic anemia in individuals with glucose-6-phosphate dehydrogenase (G6PD) deficiency, an inherited enzyme condition. A quantitative G6PD blood test must be performed and confirm normal enzyme activity before Arakoda can be prescribed. This is a non-negotiable safety requirement.
- Not for pregnant or breastfeeding women. Arakoda should not be used during pregnancy or while breastfeeding an infant who has not been tested for G6PD deficiency.
- Psychiatric history. Like mefloquine, tafenoquine carries warnings regarding neuropsychiatric side effects. Patients with a history of psychotic disorders or current psychotic symptoms should not take Arakoda. Because tafenoquine has a long half-life, any side effects may persist for weeks after stopping the medication.
- Age requirement. Arakoda is approved for adults aged 18 years and older. It is not currently approved for pediatric use.
Common side effects are generally mild and may include headache, dizziness, nausea, and vivid or abnormal dreams. Most travelers tolerate the medication well.
Malaria Prevention India Travel: A Complete Checklist
Beyond antimalarial medication, a comprehensive approach to malaria prevention for India travel includes multiple layers of protection:
- Consult a travel health provider at least 4-6 weeks before your trip (though Arakoda’s short loading period allows for last-minute consultations too).
- Get your G6PD test if you are considering Arakoda. Your provider can order this as part of your pre-travel consultation.
- Start your antimalarial on schedule — for Arakoda, that means daily dosing for three days before entering the endemic area, then weekly thereafter.
- Pack insect repellent containing at least 20-30% DEET, picaridin, or oil of lemon eucalyptus.
- Wear protective clothing during dusk and dawn when Anopheles mosquitoes are most active.
- Sleep under a treated bed net if your accommodation lacks screens or air conditioning — common in budget guesthouses and rural homestays across India.
- Treat clothing with permethrin for added protection, especially if you are trekking or spending extended time outdoors.
- Complete your post-travel dose — one final Arakoda tablet seven days after leaving the endemic area.
How to Get an Arakoda Prescription Through Runway Health
Getting a prescription for Arakoda does not require an in-person visit to a travel clinic. With Runway Health, you can complete the entire process online from the comfort of your home:
- Start a free online consultation. Answer a few questions about your travel plans, medical history, and any medications you are currently taking. The process takes about five minutes.
- Get matched with a licensed provider. A healthcare provider reviews your information, confirms that Arakoda is appropriate for you, and writes your prescription. They may recommend a G6PD test if you have not already had one.
- Receive your medication by mail. Your prescription is filled and shipped directly to your door, typically arriving within a few business days — well before your departure date.
No waiting rooms, no scheduling hassles, and no last-minute scrambles to find a travel health clinic with availability. Runway Health makes malaria prevention for India travel as straightforward as booking your flight.
Frequently Asked Questions
Q: Do I need malaria pills for India even if I am only visiting cities?
Yes, in most cases. The CDC recommends antimalarial prophylaxis for travel to areas below 2,000 meters in India, and that includes major cities like Delhi, Mumbai, Kolkata, and Chennai. While the risk is lower in urban centers compared to rural and forested areas, malaria transmission still occurs in Indian cities — particularly in peri-urban zones and areas with poor drainage.
Q: Is Arakoda better than Malarone for India travel?
Both are effective antimalarials approved by the CDC for India. The main advantage of Arakoda is its weekly dosing, which is significantly more convenient for extended trips. Malarone requires daily dosing and a longer post-travel course. For travelers spending two or more weeks in India, Arakoda’s simplified schedule often makes it the preferred choice. Read more about choosing the right antimalarial.
Q: What is the G6PD test, and why is it required for Arakoda?
G6PD (glucose-6-phosphate dehydrogenase) is an enzyme that protects red blood cells from damage. Some people have an inherited deficiency of this enzyme. Tafenoquine, the active ingredient in Arakoda, can cause severe hemolytic anemia (destruction of red blood cells) in people with G6PD deficiency. A simple blood test confirms whether your G6PD levels are normal. This test must be done before Arakoda can be prescribed.
Q: Can I take Arakoda if I am traveling to India for just one week?
Yes. Arakoda can be used for trips of any length. The loading dose is three consecutive days before travel, followed by one weekly dose during your trip, and one dose after leaving the endemic area. Even for shorter trips, the convenience of not having to remember a daily pill can be valuable.
Q: When is the worst time to travel to India for malaria risk?
The highest malaria transmission in India occurs from July through November, during and immediately after the monsoon season. September and October typically see the peak case numbers. However, malaria risk exists year-round in many parts of India, so prophylaxis is recommended regardless of when you travel.
Protect Yourself and Enjoy India With Confidence
India offers extraordinary experiences for travelers — from the Taj Mahal to Kerala’s backwaters, from Rajasthan’s desert forts to the misty hills of the northeast. Malaria should not keep you from exploring this incredible country, but it does demand respect and preparation. With the right antimalarial medication and protective measures, you can focus on the adventure rather than the risk.
Arakoda (tafenoquine) offers a modern, convenient solution for malaria prevention during India travel, with its once-weekly dosing, short lead time, and brief post-travel course. It is especially well-suited for the extended, multi-city itineraries that India inspires.
Ready to get protected before your India trip? Start your free online consultation with Runway Health today and get your antimalarial prescription delivered to your door.
